The Living Guidelines: UA/NSTEMI Recommendations for Anti Ischemic Therapy Polling Results for CLASS IIb Guidelines

Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, WikiDoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Class IIb Guidelines
1. The use of extended-release forms of non dihydropyridine calcium antagonists instead of a beta blocker may be considered in patients with UA/NSTEMI. (Level of Evidence: B)

 UA/NSTEMI Guidelines Class IIb Recommendation 1 for Anti Ischemic Therapy should be: CLASS I CLASS IIa CLASS IIb CLASS III

2. Immediate-release dihydropyridine calcium antagonists in the presence of adequate beta blockade may be considered in patients with UA/NSTEMI with ongoing ischemic symptoms or hypertension. (Level of Evidence: B)

 UA/NSTEMI Guidelines Class IIb Recommendation 2 for Anti Ischemic Therapy should be: CLASS I CLASS IIa CLASS IIb CLASS III